Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Foramen Ovale, Patent | 12 | 2021 | 214 | 4.070 |
Why?
|
Stroke | 32 | 2024 | 9962 | 1.950 |
Why?
|
Thrombophilia | 3 | 2021 | 306 | 1.220 |
Why?
|
Subarachnoid Hemorrhage | 7 | 2021 | 1032 | 1.080 |
Why?
|
Embolism, Paradoxical | 3 | 2021 | 55 | 0.950 |
Why?
|
Gelsolin | 2 | 2014 | 189 | 0.800 |
Why?
|
Proteomics | 7 | 2017 | 3817 | 0.760 |
Why?
|
Ischemic Attack, Transient | 7 | 2021 | 901 | 0.740 |
Why?
|
Hemorrhagic Disorders | 2 | 2012 | 35 | 0.680 |
Why?
|
Atrial Appendage | 1 | 2023 | 292 | 0.660 |
Why?
|
Heart Arrest | 3 | 2023 | 1506 | 0.610 |
Why?
|
Glycoproteins | 2 | 2017 | 2208 | 0.580 |
Why?
|
Embolism | 1 | 2020 | 408 | 0.570 |
Why?
|
Tissue Plasminogen Activator | 8 | 2022 | 1190 | 0.480 |
Why?
|
Hypothermia, Induced | 2 | 2017 | 758 | 0.470 |
Why?
|
Brain Ischemia | 9 | 2024 | 3127 | 0.470 |
Why?
|
Blood-Brain Barrier | 3 | 2024 | 1019 | 0.440 |
Why?
|
Vertebral Artery Dissection | 1 | 2013 | 51 | 0.440 |
Why?
|
Mass Spectrometry | 4 | 2021 | 2192 | 0.430 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.410 |
Why?
|
Molecular Probe Techniques | 1 | 2013 | 117 | 0.410 |
Why?
|
Matrix Metalloproteinase 9 | 5 | 2011 | 632 | 0.370 |
Why?
|
Lectins | 1 | 2013 | 484 | 0.370 |
Why?
|
Migraine Disorders | 5 | 2020 | 1693 | 0.350 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1647 | 0.340 |
Why?
|
Apolipoproteins | 1 | 2012 | 320 | 0.340 |
Why?
|
Endothelial Cells | 6 | 2024 | 3539 | 0.330 |
Why?
|
Cerebral Infarction | 2 | 2013 | 982 | 0.330 |
Why?
|
ROC Curve | 2 | 2017 | 3568 | 0.310 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1436 | 0.310 |
Why?
|
Brain | 15 | 2022 | 26951 | 0.310 |
Why?
|
Blood Proteins | 3 | 2012 | 1173 | 0.310 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 448 | 0.290 |
Why?
|
Microglia | 4 | 2020 | 1351 | 0.290 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4357 | 0.280 |
Why?
|
Brain Edema | 1 | 2011 | 603 | 0.280 |
Why?
|
Recurrence | 6 | 2021 | 8482 | 0.280 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1189 | 0.270 |
Why?
|
Thrombolytic Therapy | 7 | 2022 | 2108 | 0.270 |
Why?
|
Fibrinolytic Agents | 6 | 2022 | 2167 | 0.260 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 151 | 0.260 |
Why?
|
Endothelium, Vascular | 3 | 2018 | 4433 | 0.260 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 623 | 0.260 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1501 | 0.260 |
Why?
|
Treatment Outcome | 15 | 2023 | 65017 | 0.250 |
Why?
|
Proteome | 3 | 2012 | 1855 | 0.250 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1084 | 0.240 |
Why?
|
Oxidative Stress | 3 | 2010 | 3106 | 0.240 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2005 | 68 | 0.240 |
Why?
|
Septal Occluder Device | 3 | 2020 | 126 | 0.240 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5209 | 0.240 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1276 | 0.230 |
Why?
|
Blood Vessels | 1 | 2009 | 1112 | 0.210 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1023 | 0.200 |
Why?
|
Humans | 62 | 2024 | 760621 | 0.200 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2942 | 0.200 |
Why?
|
Tight Junctions | 1 | 2024 | 315 | 0.190 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2013 | 110 | 0.190 |
Why?
|
Streptococcal Infections | 1 | 2005 | 617 | 0.180 |
Why?
|
Influenza, Human | 1 | 2011 | 1528 | 0.170 |
Why?
|
Signal Transduction | 3 | 2013 | 23376 | 0.170 |
Why?
|
Coma | 1 | 2023 | 487 | 0.170 |
Why?
|
Male | 41 | 2024 | 359744 | 0.170 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2022 | 892 | 0.150 |
Why?
|
Brain Death | 1 | 2001 | 356 | 0.150 |
Why?
|
Spinal Injuries | 1 | 2001 | 300 | 0.150 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1881 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 640 | 0.150 |
Why?
|
Alzheimer Disease | 2 | 2022 | 8547 | 0.150 |
Why?
|
Ceruloplasmin | 1 | 2017 | 56 | 0.150 |
Why?
|
Annexin A2 | 1 | 2017 | 44 | 0.140 |
Why?
|
Echocardiography | 2 | 2020 | 4981 | 0.140 |
Why?
|
Female | 31 | 2024 | 391270 | 0.140 |
Why?
|
Algorithms | 2 | 2019 | 13981 | 0.130 |
Why?
|
Anticoagulants | 2 | 2023 | 4897 | 0.130 |
Why?
|
Haptoglobins | 1 | 2017 | 167 | 0.130 |
Why?
|
Middle Aged | 23 | 2024 | 220352 | 0.130 |
Why?
|
Secondary Prevention | 2 | 2020 | 1548 | 0.130 |
Why?
|
Extracellular Fluid | 1 | 2017 | 165 | 0.130 |
Why?
|
Extracellular Space | 1 | 2018 | 564 | 0.130 |
Why?
|
Intracranial Embolism | 2 | 2017 | 192 | 0.130 |
Why?
|
Central Nervous System Diseases | 2 | 2018 | 521 | 0.130 |
Why?
|
Prospective Studies | 8 | 2024 | 54303 | 0.130 |
Why?
|
Oxygen | 2 | 2018 | 4193 | 0.130 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11903 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1717 | 0.130 |
Why?
|
Cadherins | 1 | 2020 | 898 | 0.120 |
Why?
|
Cervical Vertebrae | 1 | 2001 | 978 | 0.120 |
Why?
|
Glucose | 2 | 2018 | 4351 | 0.120 |
Why?
|
Endocarditis | 1 | 2019 | 351 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 3 | 2013 | 1431 | 0.120 |
Why?
|
Mitochondria | 2 | 2018 | 3600 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1266 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2017 | 916 | 0.120 |
Why?
|
Coronary Circulation | 1 | 2020 | 1577 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2001 | 924 | 0.110 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 844 | 0.110 |
Why?
|
Adult | 18 | 2021 | 219994 | 0.110 |
Why?
|
Astrocytes | 2 | 2018 | 1338 | 0.110 |
Why?
|
Prognosis | 9 | 2024 | 29658 | 0.110 |
Why?
|
Animals | 23 | 2024 | 167963 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2024 | 1952 | 0.100 |
Why?
|
Polyvinyls | 1 | 2013 | 154 | 0.100 |
Why?
|
Recovery of Function | 3 | 2020 | 2985 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1380 | 0.100 |
Why?
|
Endothelin-1 | 1 | 2013 | 302 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 311 | 0.100 |
Why?
|
Chemokines | 1 | 2016 | 962 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1047 | 0.100 |
Why?
|
Metalloendopeptidases | 1 | 2013 | 393 | 0.100 |
Why?
|
Aged | 16 | 2024 | 169152 | 0.090 |
Why?
|
Limit of Detection | 1 | 2012 | 280 | 0.090 |
Why?
|
Membranes, Artificial | 1 | 2013 | 367 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 418 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 785 | 0.090 |
Why?
|
Cell Communication | 1 | 2018 | 1653 | 0.090 |
Why?
|
Dizziness | 1 | 2013 | 257 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2044 | 0.090 |
Why?
|
Papilledema | 1 | 2012 | 130 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 1744 | 0.090 |
Why?
|
Nerve Regeneration | 1 | 2016 | 791 | 0.090 |
Why?
|
Vomiting | 1 | 2013 | 650 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10756 | 0.090 |
Why?
|
Rats, Wistar | 3 | 2022 | 1850 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 211 | 0.090 |
Why?
|
Cytotoxins | 1 | 2010 | 153 | 0.080 |
Why?
|
Glycosylation | 1 | 2013 | 1096 | 0.080 |
Why?
|
Fibrinogen | 1 | 2013 | 886 | 0.080 |
Why?
|
Biomedical Technology | 1 | 2012 | 211 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2571 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 214 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4000 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2014 | 1697 | 0.080 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 987 | 0.080 |
Why?
|
Hydrocephalus | 2 | 2013 | 763 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3364 | 0.080 |
Why?
|
F2-Isoprostanes | 1 | 2007 | 35 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15757 | 0.080 |
Why?
|
Rats | 6 | 2022 | 23711 | 0.070 |
Why?
|
Thrombospondin 1 | 1 | 2009 | 257 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3201 | 0.070 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2008 | 140 | 0.070 |
Why?
|
Time Factors | 7 | 2020 | 40165 | 0.070 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2012 | 1112 | 0.070 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 87 | 0.070 |
Why?
|
Pneumocephalus | 1 | 2006 | 47 | 0.070 |
Why?
|
Convalescence | 1 | 2006 | 106 | 0.070 |
Why?
|
Spinal Cord Diseases | 1 | 2008 | 293 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2006 | 452 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2809 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 267 | 0.060 |
Why?
|
Cerebral Hemorrhage | 3 | 2009 | 2660 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2013 | 22053 | 0.060 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 538 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2007 | 493 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 530 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22023 | 0.060 |
Why?
|
Plasminogen Activators | 1 | 2004 | 199 | 0.060 |
Why?
|
Organic Cation Transport Proteins | 1 | 2024 | 58 | 0.060 |
Why?
|
Age Factors | 2 | 2016 | 18416 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1173 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16546 | 0.060 |
Why?
|
Deoxyribonucleases | 1 | 2005 | 212 | 0.060 |
Why?
|
Leukocytosis | 1 | 2005 | 251 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3334 | 0.060 |
Why?
|
Retinal Diseases | 2 | 2000 | 702 | 0.060 |
Why?
|
Methylprednisolone | 1 | 2005 | 384 | 0.060 |
Why?
|
Pharyngitis | 1 | 2005 | 220 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58995 | 0.050 |
Why?
|
Ischemia | 1 | 2012 | 1893 | 0.050 |
Why?
|
Cell Death | 2 | 2024 | 1672 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3267 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18137 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6498 | 0.050 |
Why?
|
Eye Diseases | 1 | 2008 | 651 | 0.050 |
Why?
|
China | 2 | 2019 | 2339 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3215 | 0.050 |
Why?
|
Cell Hypoxia | 2 | 2018 | 658 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2006 | 1600 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2005 | 552 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 17790 | 0.050 |
Why?
|
Cohort Studies | 3 | 2018 | 41335 | 0.050 |
Why?
|
Echo-Planar Imaging | 1 | 2006 | 657 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 58741 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 2018 | 8158 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9426 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2010 | 2141 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2022 | 278 | 0.050 |
Why?
|
Risk Factors | 6 | 2024 | 74359 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2004 | 554 | 0.050 |
Why?
|
Neostigmine | 1 | 2021 | 68 | 0.050 |
Why?
|
Nasal Polyps | 1 | 2006 | 395 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 12965 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17624 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 664 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2009 | 1182 | 0.040 |
Why?
|
Sulfur Hexafluoride | 1 | 2000 | 26 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13451 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 18957 | 0.040 |
Why?
|
Silicone Oils | 1 | 2000 | 22 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4407 | 0.040 |
Why?
|
Cell Line | 2 | 2010 | 15620 | 0.040 |
Why?
|
Mice | 7 | 2024 | 81208 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2001 | 579 | 0.040 |
Why?
|
Heart | 1 | 2012 | 4393 | 0.040 |
Why?
|
Air | 1 | 2000 | 186 | 0.040 |
Why?
|
Aging | 1 | 2018 | 8651 | 0.040 |
Why?
|
Pregnancy | 2 | 2016 | 29749 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1540 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2699 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3804 | 0.040 |
Why?
|
Retina | 2 | 2000 | 2635 | 0.040 |
Why?
|
Aplysia | 1 | 1998 | 40 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8594 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 544 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6597 | 0.040 |
Why?
|
Heart Atria | 1 | 2024 | 1346 | 0.040 |
Why?
|
Reperfusion | 1 | 2018 | 271 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2010 | 691 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2022 | 1110 | 0.030 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 1998 | 293 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2018 | 281 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 296 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1126 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6180 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2006 | 2056 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1998 | 498 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1796 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7269 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36290 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 530 | 0.030 |
Why?
|
Fluorocarbons | 1 | 2000 | 488 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12293 | 0.030 |
Why?
|
Microvessels | 1 | 2018 | 572 | 0.030 |
Why?
|
Neovascularization, Physiologic | 2 | 2012 | 1336 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20509 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2782 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 768 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39261 | 0.030 |
Why?
|
Serotonin | 1 | 1998 | 1040 | 0.030 |
Why?
|
Bradykinin | 1 | 2013 | 208 | 0.030 |
Why?
|
Benzofurans | 1 | 2013 | 142 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2672 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1674 | 0.030 |
Why?
|
Neuroglia | 1 | 2018 | 944 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15840 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 961 | 0.020 |
Why?
|
Species Specificity | 1 | 2016 | 2418 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5125 | 0.020 |
Why?
|
Intracranial Thrombosis | 1 | 2012 | 109 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2019 | 15697 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 388 | 0.020 |
Why?
|
Glycemic Index | 1 | 2012 | 396 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12808 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9530 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15289 | 0.020 |
Why?
|
Patient Selection | 2 | 2013 | 4283 | 0.020 |
Why?
|
Hospitals, General | 1 | 2013 | 795 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3832 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2283 | 0.020 |
Why?
|
Iliac Vein | 1 | 2009 | 70 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2913 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1098 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1664 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 461 | 0.020 |
Why?
|
Phlebography | 1 | 2009 | 325 | 0.020 |
Why?
|
Vitreous Body | 2 | 2000 | 399 | 0.020 |
Why?
|
Posterior Cerebral Artery | 1 | 2007 | 35 | 0.020 |
Why?
|
Neuroimmunomodulation | 1 | 2009 | 177 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6538 | 0.020 |
Why?
|
alpha-Tocopherol | 1 | 2007 | 126 | 0.020 |
Why?
|
Anterior Cerebral Artery | 1 | 2007 | 50 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 4371 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2004 | 4673 | 0.020 |
Why?
|
Injections | 2 | 2000 | 830 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4122 | 0.020 |
Why?
|
Basilar Artery | 1 | 2007 | 205 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2007 | 276 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2698 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 80372 | 0.020 |
Why?
|
Myocardium | 1 | 2018 | 4700 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3928 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8056 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 87810 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2001 | 8950 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2007 | 655 | 0.010 |
Why?
|
Urinary Incontinence | 1 | 2008 | 495 | 0.010 |
Why?
|
Oligopeptides | 1 | 2009 | 1187 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13314 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2295 | 0.010 |
Why?
|
Rabbits | 2 | 2000 | 4773 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7588 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6544 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3726 | 0.010 |
Why?
|
Metabolomics | 1 | 2012 | 1628 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10344 | 0.010 |
Why?
|
Quality of Life | 1 | 2004 | 13308 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 392 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3280 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2004 | 593 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15687 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2007 | 1440 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9280 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9335 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5797 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2006 | 1420 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2007 | 1826 | 0.010 |
Why?
|
Antioxidants | 1 | 2007 | 1667 | 0.010 |
Why?
|
Blood Glucose | 1 | 2012 | 6381 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14660 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 25942 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5206 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 2001 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2004 | 1726 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9411 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1705 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 286 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 478 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5794 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 483 | 0.010 |
Why?
|
Safety | 1 | 2000 | 1148 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 1991 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2000 | 1167 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14372 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1792 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2753 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2176 | 0.010 |
Why?
|
Survivors | 1 | 2004 | 2375 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8525 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4169 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1998 | 3602 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21392 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1998 | 2440 | 0.010 |
Why?
|
Base Sequence | 1 | 1998 | 12446 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5791 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9585 | 0.000 |
Why?
|